4
Changes in Ownership
KIORA PHARMACEUTICALS INC Filed Acc 0000899243-21-030722
Director sold 3,153,138 shares at an average $4.61 ($14,546,264)
- Director acquired 852,500 shares (conversion)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| ARMISTICE CAPITAL, LLC Director | 2021-07-27 | Conversion | +852,500 | $4.80 | $4,092,000 | 4,199,101 | I |
| ARMISTICE CAPITAL, LLC Director | 2021-07-27 | Sale | −73,101 | $7.06 | $516,108 | 4,126,000 | I |
| ARMISTICE CAPITAL, LLC Director | 2021-07-27 | Sale | −461,797 | $6.45 | $2,980,853 | 3,664,203 | I |
| ARMISTICE CAPITAL, LLC Director | 2021-07-27 | Sale | −729,114 | $5.44 | $3,966,161 | 2,935,089 | I |
| ARMISTICE CAPITAL, LLC Director | 2021-07-27 | Sale | −532,069 | $4.59 | $2,440,973 | 2,403,020 | I |
| ARMISTICE CAPITAL, LLC Director | 2021-07-27 | Sale | −581,614 | $3.80 | $2,209,552 | 1,821,406 | I |
| ARMISTICE CAPITAL, LLC Director | 2021-07-28 | Sale | −375,443 | $3.28 | $1,232,617 | 1,445,963 | I |
| ARMISTICE CAPITAL, LLC Director | 2021-07-29 | Sale | −400,000 | $3.00 | $1,200,000 | 1,045,963 | I |
| Derivatives | |||||||
| ARMISTICE CAPITAL, LLC Director | 2021-07-27 | Conversion · Series C Convertible Preferred Stock | −4,092 | 0 | I | ||
| Open-market sales · 3,153,138 sh · avg $4.61 · $14,546,264 | |||||||
Loading xslF345X03/doc4.xml…